Cardiovascular risk assessment and lipid modification: NICE guideline

scientific article published on July 2015

Cardiovascular risk assessment and lipid modification: NICE guideline is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3399/BJGP15X685933
P932PMC publication ID4484941
P698PubMed publication ID26120133

P50authorNadeem QureshiQ40731118
P2093author name stringNorma O'Flynn
Martin Duerden
P2860cites workQuantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisQ24679573
What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choiceQ34409791
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysisQ34411415
Major lipids, apolipoproteins, and risk of vascular diseaseQ35771393
Statins for the primary prevention of cardiovascular diseaseQ38182548
Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular diseaseQ81780779
P433issue636
P304page(s)378-380
P577publication date2015-07-01
P1433published inBritish Journal of General PracticeQ15758540
P1476titleCardiovascular risk assessment and lipid modification: NICE guideline
P478volume65

Reverse relations

cites work (P2860)
Q98291680A 10-Year Risk of Cardiovascular Disease among Patients with Severe Mental Illness at Mbarara Regional Referral Hospital, Southwestern Uganda
Q99617634Cardiovascular/stroke risk predictive calculators: a comparison between statistical and machine learning models
Q30252911Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study
Q89495878Effects of aged garlic extract on arterial elasticity in a placebo-controlled clinical trial using EndoPAT™ technology
Q57091674Excessive Erythrocytosis and Cardiovascular Risk in Andean Highlanders
Q97529533Exercise versus fixed-dose combination therapy for cardiovascular risk factors control and atherosclerotic disease prevention: a network meta-analysis protocol

Search more.